Nylim US LG Ca R&D LD ETF-UiLRNDETF
13F holders, Q4 2024 (December 31)3holders
1new positions
1sold out
$34.14avg. 13F price*
At the end of Q4 2024, 3 institutions reported holding Nylim US LG Ca R&D LD ETF-Ui (LRND) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 1 sold out. The largest holders were New York Life Investment Management LLC ($6.5M), GTS Securities LLC ($578K) and UBS Group AG ($2K).
- Company
- Nylim US LG Ca R&D LD ETF-Ui
- Filed as
- NEW YORK LIFE INVESTMENTS ET (Q4 2024)
- CUSIP
- 45409B263
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2K |
| Exits | 1 | $2K |
All 13F filers, Q3 2024 → Q4 2024: 8,127 shares bought and 66 shares sold, net +8,061 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 3 holders
| New York Life Investment Management LLC | 0.06% | No change | 190,000 | $6.5M |
| GTS Securities LLC | 0.03% | Add +90.9% | 16,936 | $578K |
| UBS Group AG | 0.00% | New | 62 | $2K |
"% of holder's portfolio" is LRND's weight in each manager's 13F, not the share of Nylim US LG Ca R&D LD ETF-Ui the manager owns.